Shares of Genpact Limited (NYSE:G - Get Free Report) have been given an average recommendation of "Hold" by the nine ratings firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $41.89.
A number of research analysts have weighed in on G shares. Wall Street Zen cut shares of Genpact from a "buy" rating to a "hold" rating in a research report on Saturday, November 7th. Weiss Ratings raised shares of Genpact from a "hold (c-)" rating to a "hold (c)" rating in a research report on Wednesday, October 14th. TD Cowen increased their target price on Genpact from $42.00 to $43.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Susquehanna increased their target price on Genpact from $40.00 to $42.00 and gave the company a "neutral" rating in a research note on Friday, November 6th. Finally, JPMorgan Chase & Co. raised their target price on Genpact from $40.00 to $45.00 and gave the company a "neutral" rating in a report on Friday, August 7th.
Get Our Latest Stock Report on G
Genpact News Summary
Here's some of the latest news about G:
- Positive Sentiment: Recent coverage highlighted a 30.3% jump in technology revenue, which could reinforce optimism about growth in Genpact’s technology-focused business. Genpact stock gains as technology revenue jumps 30.3 percent
- Neutral Sentiment: Genpact’s new survey found that while 79% of enterprises have AI agents in production, only 15% have tied AI investment to profit-and-loss outcomes. This highlights a significant opportunity for Genpact’s operations expertise, but also shows that converting AI adoption into measurable business value remains a challenge. Genpact report on AI agents and business value
- Negative Sentiment: Senior Vice President Piyush Mehta sold 200,000 shares for about $8.61 million, cutting his direct holdings by 56.05%. The large insider sale could raise concerns, although it does not by itself indicate a change in the company’s outlook. SEC filing for Piyush Mehta share sale
Insider Activity
In other Genpact news, SVP Piyush Mehta sold 200,000 shares of Genpact stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $43.05, for a total transaction of $8,610,000.00. Following the sale, the senior vice president directly owned 156,823 shares in the company, valued at $6,751,230.15. The trade was a 56.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Anil Nanduru sold 6,191 shares of the company's stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $37.03, for a total value of $229,252.73. Following the completion of the transaction, the senior vice president directly owned 70,253 shares in the company, valued at approximately $2,601,468.59. The trade was a 8.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.58% of the stock is owned by company insiders.
Hedge Funds Weigh In On Genpact
Several large investors have recently modified their holdings of the stock. Bleakley Financial Group LLC grew its stake in Genpact by 18.7% in the third quarter. Bleakley Financial Group LLC now owns 21,816 shares of the business services provider's stock worth $710,000 after purchasing an additional 3,442 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of Genpact by 15.2% in the 3rd quarter. First Trust Advisors LP now owns 3,306,215 shares of the business services provider's stock valued at $107,551,000 after acquiring an additional 437,236 shares during the last quarter. Focus Advisor Solutions LLC acquired a new stake in shares of Genpact during the 3rd quarter valued at approximately $398,000. OneAscent Financial Services LLC raised its holdings in shares of Genpact by 14.9% during the third quarter. OneAscent Financial Services LLC now owns 13,141 shares of the business services provider's stock worth $427,000 after purchasing an additional 1,705 shares during the period. Finally, Hudson Portfolio Management LLC acquired a new stake in shares of Genpact during the third quarter worth $246,000. Institutional investors own 96.03% of the company's stock.
Genpact Price Performance
G opened at $43.67 on Friday. The company's 50 day simple moving average is $37.07 and its 200 day simple moving average is $35.47. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.00 and a current ratio of 1.95. Genpact has a 1 year low of $26.85 and a 1 year high of $48.64. The stock has a market capitalization of $7.30 billion, a PE ratio of 12.73, a P/E/G ratio of 1.12 and a beta of 0.53.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The business services provider reported $1.07 EPS for the quarter, topping analysts' consensus estimates of $1.04 by $0.03. Genpact had a return on equity of 23.02% and a net margin of 11.04%. The company's revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.97 earnings per share. As a group, sell-side analysts expect that Genpact will post 3.66 EPS for the current year.
Genpact Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 23rd. Shareholders of record on Thursday, December 10th will be given a $0.1875 dividend. This represents a $0.75 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Thursday, December 10th. Genpact's dividend payout ratio is presently 21.87%.
About Genpact
(
Get Free Report)
Genpact is a global professional services company that helps businesses improve operations and pursue digital transformation. Its services include business process management, consulting, data and analytics, artificial intelligence, and technology implementation. The company works with clients across industries such as banking and financial services, insurance, consumer goods, healthcare, life sciences, manufacturing, and technology. It serves organizations around the world through its global operations.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.